Critical Path Institute
Date of Award
Type 1 Diabetes: Prevent and Delay T1D
Term of Grant
Type 1 Diabetes (T1D) Biomarker Consortium
Funds will support the Critical Path Institute and its partners in regulatory qualification of islet autoantibodies as biomarkers of disease in type 1 diabetes.